Ensign Peak Advisors
PFE icon

Ensign Peak Advisors’s Pfizer PFE Stock Holding History

Ensign Peak Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123M Buy
5,127,377
+298,140
+6% +$7.8M 0.2% 98
2026
Q1 		$136M Sell
4,829,237
-528,187
-10% -$14.1M 0.25% 87
2025
Q4 		$133M Buy
5,357,424
+233,752
+5% +$5.89M 0.24% 87
2025
Q3 		$131M Sell
5,123,672
-84,102
-2% -$2.08M 0.21% 96
2025
Q2 		$126M Sell
5,207,774
-1,094,238
-17% -$25.5M 0.22% 97
2025
Q1 		$160M Sell
6,302,012
-142,999
-2% -$3.74M 0.31% 72
2024
Q4 		$171M Buy
6,445,011
+1,383,305
+27% +$37.5M 0.3% 63
2024
Q3 		$146M Sell
5,061,706
-102,063
-2% -$2.98M 0.26% 78
2024
Q2 		$144M Sell
5,163,769
-261,578
-5% -$7.2M 0.26% 75
2024
Q1 		$151M Buy
5,425,347
+363,032
+7% +$10.1M 0.28% 74
2023
Q4 		$146M Buy
5,062,315
+1,771,860
+54% +$53.6M 0.29% 74
2023
Q3 		$109M Sell
3,290,455
-248,974
-7% -$8.8M 0.23% 91
2023
Q2 		$130M Sell
3,539,429
-1,797,819
-34% -$70M 0.26% 86
2023
Q1 		$218M Sell
5,337,248
-584,788
-10% -$25.3M 0.47% 54
2022
Q4 		$303M Sell
5,922,036
-521,478
-8% -$25M 0.68% 31
2022
Q3 		$282M Buy
6,443,514
+607,762
+10% +$29.5M 0.7% 34
2022
Q2 		$306M Buy
5,835,752
+80,888
+1% +$4.12M 0.73% 30
2022
Q1 		$298M Sell
5,754,864
-945,041
-14% -$49M 0.61% 35
2021
Q4 		$396M Buy
6,699,905
+1,775,904
+36% +$88M 0.76% 22
2021
Q3 		$212M Buy
4,924,001
+761,388
+18% +$33.7M 0.44% 53
2021
Q2 		$163M Sell
4,162,613
-48,755
-1% -$1.9M 0.33% 83
2021
Q1 		$153M Sell
4,211,368
-72,326
-2% -$2.57M 0.33% 83
2020
Q4 		$158M Buy
4,283,694
+1,530,414
+56% +$56.1M 0.36% 69
2020
Q3 		$95.9M Sell
2,753,280
-29,077
-1% -$1.02M 0.24% 83
2020
Q2 		$86.3M Buy
2,782,357
+66,129
+2% +$2.25M 0.23% 88
2020
Q1 		$84.1M Buy
2,716,228
+545,160
+25% +$18.6M 0.28% 82
2019
Q4 		$80.7M Buy
+2,171,068
New +$77.3M 0.21% 91

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ensign Peak Advisors's PFE Position: Q2 2026 in Review

Ensign Peak Advisors increased its Pfizer (PFE) stake by 6.2% in Q2 2026, buying an estimated $7.8M and bringing the position to 5,127,377 shares worth $123M. The position accounts for 0.2% of the portfolio, ranked #98.

Ensign Peak Advisors first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $396M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ensign Peak Advisors held 5,127,377 shares of Pfizer worth $123M as of Q2 2026.
  • Ensign Peak Advisors bought 298,140 Pfizer shares in Q2 2026, an estimated $7.8M.
  • Pfizer made up 0.2% of Ensign Peak Advisors's portfolio in Q2 2026, its #98 holding.
  • Ensign Peak Advisors first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Pfizer position peaked at $396M in Q4 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.